To screen ETFs by asset class, performance, yield and more, check out the
wins Copaxone trial, up almost 7%
. I'm bummed it never dropped to my limit orders at 37.5. Weird to drop good news late on Friday.
Hopefully it'll continue up a bit, looking to lighten up my position.
Add a reply...
Latest StockTalks »
people get TEVA breaking news and analysis by email alert.
Get email alerts on TEVA »
Teva Pharmaceutical Industries Limited
Get latest price
From other sites
Generics Prices Spike: 2 Stock Choices - Analyst Blog
at Zacks.com (Jan 12, 2015)
Impax Soars on FDA Nod of Parkinson's Disease Drug Rytary - Analyst Blog
at Zacks.com (Jan 9, 2015)
Drug pricing concerns? Not at Gilead
at CNBC.com (Jan 5, 2015)
OncoGenex to End Deal with Teva & Regain Custirsen Rights - Analyst Blog
at Zacks.com (Dec 31, 2014)
TEVA February 2015 Options Begin Trading
at Nasdaq.com (Dec 31, 2014)
Xignite quote data
© 2015 Seeking Alpha